Empirical Finance’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.42M | Sell |
18,241
-29
| -0.2% | -$10.3K | 0.3% | 66 |
|
|
2025
Q4 | $5.98M | Sell |
18,270
-790
| -4% | -$251K | 0.29% | 66 |
|
|
2025
Q3 | $5.38M | Buy |
19,060
+181
| +1% | +$52.5K | 0.26% | 76 |
|
|
2025
Q2 | $5.27M | Buy |
18,879
+117
| +0.6% | +$33.1K | 0.28% | 72 |
|
|
2025
Q1 | $5.85M | Buy |
18,762
+255
| +1% | +$75.3K | 0.35% | 55 |
|
|
2024
Q4 | $4.82M | Sell |
18,507
-247
| -1% | -$73.3K | 0.28% | 69 |
|
|
2024
Q3 | $6.04M | Buy |
18,754
+380
| +2% | +$124K | 0.35% | 55 |
|
|
2024
Q2 | $5.74M | Sell |
18,374
-1,399
| -7% | -$411K | 0.36% | 53 |
|
|
2024
Q1 | $5.62M | Buy |
19,773
+649
| +3% | +$190K | 0.35% | 59 |
|
|
2023
Q4 | $5.51M | Buy |
19,124
+59
| +0.3% | +$16.1K | 0.38% | 49 |
|
|
2023
Q3 | $5.12M | Buy |
19,065
+1,542
| +9% | +$385K | 0.38% | 51 |
|
|
2023
Q2 | $3.89M | Buy |
17,523
+1,965
| +13% | +$456K | 0.3% | 67 |
|
|
2023
Q1 | $3.76M | Buy |
15,558
+680
| +5% | +$167K | 0.35% | 62 |
|
|
2022
Q4 | $3.91M | Buy |
14,878
+1,041
| +8% | +$279K | 0.4% | 53 |
|
|
2022
Q3 | $3.12M | Buy |
13,837
+2,077
| +18% | +$503K | 0.37% | 55 |
|
|
2022
Q2 | $2.86M | Buy |
11,760
+601
| +5% | +$147K | 0.36% | 56 |
|
|
2022
Q1 | $2.7M | Buy |
11,159
+1,164
| +12% | +$267K | 0.3% | 64 |
|
|
2021
Q4 | $2.25M | Buy |
9,995
+2,567
| +35% | +$542K | 0.27% | 69 |
|
|
2021
Q3 | $1.58M | Buy |
7,428
+402
| +6% | +$92.5K | 0.24% | 84 |
|
|
2021
Q2 | $1.71M | Buy |
7,026
+902
| +15% | +$222K | 0.28% | 71 |
|
|
2021
Q1 | $1.41M | Hold |
6,124
| – | – | 0.25% | 105 |
|
|
2020
Q4 | $1.41M | Buy |
6,124
+1,008
| +20% | +$232K | 0.25% | 105 |
|
|
2020
Q3 | $1.3M | Buy |
5,116
+994
| +24% | +$246K | 0.28% | 95 |
|
|
2020
Q2 | $972K | Buy |
4,122
+487
| +13% | +$111K | 0.25% | 107 |
|
|
2020
Q1 | $737K | Buy |
3,635
+1,231
| +51% | +$269K | 0.23% | 104 |
|
|
2019
Q4 | $580K | Buy |
2,404
+821
| +52% | +$181K | 0.14% | 129 |
|
|
2019
Q3 | $306K | Buy |
1,583
+24
| +2% | +$4.61K | 0.09% | 134 |
|
|
2019
Q2 | $287K | Sell |
1,559
-32
| -2% | -$5.73K | 0.08% | 133 |
|
|
2019
Q1 | $302K | Sell |
1,591
-7,087
| -82% | -$1.35M | 0.08% | 136 |
|
|
2018
Q4 | $1.69M | Sell |
8,678
-132
| -1% | -$25.8K | 0.5% | 33 |
|
|
2018
Q3 | $1.83M | Sell |
8,810
-6,454
| -42% | -$1.27M | 0.45% | 32 |
|
|
2018
Q2 | $2.82M | Buy |
15,264
+13,673
| +859% | +$2.42M | 0.71% | 18 |
|
|
2018
Q1 | $302K | Sell |
1,591
-5,014
| -76% | -$920K | 0.08% | 136 |
|
|
2017
Q4 | $1.15M | Buy |
+6,605
| New | +$1.17M | 0.38% | 75 |
|
|
2017
Q1 | – | Sell |
-333
| Closed | -$49K | – | 114 |
|
|
2016
Q4 | $49K | Buy |
+333
| New | +$50.1K | 0.03% | 110 |
|
Other funds holding AMGN
VCM
VPM
Empirical Finance's AMGN Position: Q1 2026 in Review
Empirical Finance reduced its Amgen (AMGN) stake by 0.16% in Q1 2026, selling an estimated $10.3K and leaving 18,241 shares worth $6.42M. The position accounts for 0.3% of the portfolio, ranked #66.
Empirical Finance first reported a position in AMGN in Q4 2016 and has held it in 35 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Empirical Finance held 18,241 shares of Amgen worth $6.42M as of Q1 2026.
- Empirical Finance sold 29 Amgen shares in Q1 2026, an estimated $10.3K.
- Amgen made up 0.3% of Empirical Finance's portfolio in Q1 2026, its #66 holding.
- Empirical Finance first reported a position in Amgen in Q4 2016 and has held it in 35 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Empirical Finance's 13F filing for Q1 2026, filed 14 May 2026.